SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-14-011038
Filing Date
2014-02-21
Accepted
2014-02-21 16:36:40
Documents
2
Group Members
BENJAMIN ROVINSKIBRIAN J. UNDERDOWNDANIEL HETUGERALD BRUNKLUMIRA CAPITAL INVESTMENT MANAGEMENT INC.PETER VAN DER VELDENVASCO LARCINA

Document Format Files

Seq Description Document Type Size
1 SC 13D v369347_sc13d.htm SC 13D 112883
2 EXHIBIT 99.1 v369347_ex99-1.htm EX-99.1 6565
  Complete submission text file 0001144204-14-011038.txt   121437
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Subject) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88006 | Film No.: 14634090
SIC: 2834 Pharmaceutical Preparations

Mailing Address 141 ADELAIDE ST. WEST, SUITE 770 TORONTO ONTARIO CANADA M5H 3L5 A6 0000
Business Address 141 ADELAIDE ST. WEST, SUITE 770 TORONTO ONTARIO CANADA M5H 3L5 A6 0000 4162134251
LCC Legacy Holdings Inc. (Filed by) CIK: 0001229595 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6
Type: SC 13D